Hematopoietic Stem Cell Transplantation Quiz
31 Questions
2 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary function of hematopoietic stem cells (HSCs)?

  • To differentiate into hematopoiesis stem cells primarily in the bone marrow of specific bones in the body (correct)
  • To eradicate cancer cells from the body
  • To suppress the immune system
  • To prevent graft rejection during stem cell transplantation

    • What is the difference between autologous and allogeneic transplantation?

  • Autologous transplantation involves removing bone marrow or peripheral blood stem cells from the patient and administering them after harvesting, while allogeneic transplantation involves a patient receiving bone marrow from a healthy matched donor who is not an identical twin. (correct)
  • Autologous transplantation involves a patient receiving bone marrow from a healthy matched donor who is not an identical twin, while allogeneic transplantation involves removing bone marrow or peripheral blood stem cells from the patient and administering them after harvesting.
  • Allogeneic transplantation involves a patient receiving bone marrow from an identical twin, while autologous transplantation involves a patient receiving bone marrow from a healthy matched donor who is not an identical twin.
  • Allogeneic transplantation involves removing bone marrow or peripheral blood stem cells from the patient and administering them after harvesting, while autologous transplantation involves a patient receiving bone marrow from a healthy matched donor who is not an identical twin.

    • What is the purpose of myeloablative conditioning in HSCT?

  • To increase the number of circulating stem cells to the peripheral blood for harvesting
  • To use low-dose chemotherapy and/or low-dose total body irradiation, with tumor eradication depending on the graft versus tumor (GVT) effect
  • To ablate the patient’s bone marrow, eradicate cancer cells, suppress the immune system, and open spaces in bone marrow for engraftment of donor stem cells (correct)
  • To remove cancerous cells from contaminated cancer cells after stem cell collection

    • What are the advantages of using umbilical cord blood (UCB) stem cells as a source of stem cells?

    <p>Ease of collection, no risk for mother or child, and less costly than bone marrow collection</p> Signup and view all the answers

    What is the purpose of immunosuppression in HSCT?

    <p>To prevent graft rejection, eradicate host immune system, and suppress donor immune system to minimize recognition of host cells as foreign</p> Signup and view all the answers

    What are the short-term side effects of stem cell transplantation?

    <p>Nausea, vomiting, diarrhea, stomatitis, hair loss, loss of appetite, fatigue, and electrolyte wasting</p> Signup and view all the answers

    What is the criteria for engraftment following stem cell transplantation?

    <p>Sustained ANC &gt;500/mm3 for 3 consecutive days and sustained platelet count 20,000/mm3 for 7 consecutive days</p> Signup and view all the answers

    What is the difference between myeloablative and reduced intensity conditioning (RIC) regimen in HSCT?

    <p>Myeloablative conditioning uses high-dose chemotherapy and/or radiation to ablate the patient’s bone marrow, while RIC regimen uses a much-reduced conditioning regimen</p> Signup and view all the answers

    What is the purpose of myeloablative conditioning?

    <p>To eradicate cancer cells and suppress the immune system.</p> Signup and view all the answers

    What is a potential advantage of reduced intensity conditioning (RIC) regimen?

    <p>It causes less toxicity and mixed chimerism upon engraftment.</p> Signup and view all the answers

    What is the purpose of stem cell mobilization?

    <p>To increase the number of circulating stem cells in the peripheral blood for harvesting.</p> Signup and view all the answers

    What is the advantage of using umbilical cord blood (UCB) stem cells as a donor source?

    <p>UCB stem cells are easier to collect and carry no risk for the mother or child.</p> Signup and view all the answers

    What is the purpose of immunosuppression in HSCT?

    <p>To prevent graft rejection, eradicate host immune system, and suppress donor immune system.</p> Signup and view all the answers

    What are the engraftment criteria for stem cell transplantation?

    <p>Sustained ANC &gt;500/mm3 for 3 consecutive days and sustained platelet count 20,000/mm3 for 7 consecutive days.</p> Signup and view all the answers

    What are the long-term side effects of stem cell transplantation?

    <p>Secondary malignancies, reproductive and sexual issues, body image changes, skin changes, and memory loss.</p> Signup and view all the answers

    What is the purpose of hematopoietic stem cell transplantation (HSCT)?

    <p>To re-establish normal hematopoietic and immune function</p> Signup and view all the answers

    What is the difference between autologous and allogeneic transplantation?

    <p>Autologous transplantation uses the patient's own stem cells, while allogeneic transplantation uses a donor's stem cells</p> Signup and view all the answers

    What is the advantage of reduced intensity conditioning (RIC) regimen in stem cell transplantation?

    <p>It causes less toxicity, mixed chimerism upon engraftment, and less graft vs. host disease (GVHD)</p> Signup and view all the answers

    What is the primary function of immunosuppression in stem cell transplantation?

    <p>To prevent graft rejection, eradicate host immune system, and suppress donor immune system to minimize recognition of host cells as foreign</p> Signup and view all the answers

    What are the criteria for engraftment in stem cell transplantation?

    <p>Sustained ANC &gt;500/mm3 for 3 consecutive days and sustained platelet count 20,000/mm3 for 7 consecutive days</p> Signup and view all the answers

    What are the short-term side effects of stem cell transplantation?

    <p>Nausea, vomiting, diarrhea, stomatitis, hair loss, loss of appetite, fatigue, and electrolyte wasting</p> Signup and view all the answers

    What are the long-term side effects of stem cell transplantation?

    <p>Secondary malignancies, reproductive and sexual issues, body image changes, skin changes, and memory loss</p> Signup and view all the answers

    What is the advantage of using umbilical cord blood (UCB) stem cells as a source of stem cells?

    <p>Ease of collection, no risk for mother or child, and less costly than bone marrow collection</p> Signup and view all the answers

    What is the primary source of hematopoiesis stem cells in the body?

    <p>Bone marrow</p> Signup and view all the answers

    What is the main difference between autologous and allogeneic transplantation?

    <p>Allogeneic transplantation involves a patient receiving bone marrow from a healthy matched donor who is not an identical twin.</p> Signup and view all the answers

    What is the purpose of myeloablative conditioning in HSCT?

    <p>To eradicate cancer cells</p> Signup and view all the answers

    What is the preferred conditioning regimen for elderly patients undergoing HSCT?

    <p>Reduced intensity conditioning</p> Signup and view all the answers

    What is the purpose of immunosuppression in HSCT?

    <p>All of the above</p> Signup and view all the answers

    What are some common immunosuppressants used in HSCT?

    <p>Calcineurin inhibitors, mycophenolate mofetil, methotrexate</p> Signup and view all the answers

    What are some potential long-term side effects of stem cell transplantation?

    <p>Secondary malignancies, reproductive and sexual issues, body image changes</p> Signup and view all the answers

    What is engraftment failure in HSCT?

    <p>The failure of the donor stem cells to engraft in the recipient's bone marrow</p> Signup and view all the answers

    Study Notes

    Hematopoietic Stem Cell Transplantation: Types, Donor Sources, and Conditioning Regimens

    • Hematopoietic stem cell transplantation (HSCT) involves infusing hematopoietic progenitor stem cells (HPCs) from a donor to a recipient after a preparative regimen of chemotherapy and/or radiation to re-establish normal hematopoietic and immune function.

    • HSCT is used to treat and cure various malignant and non-malignant disorders.

    • Hematopoietic stem cells (HSCs) are pluripotent stem cells that differentiate into hematopoiesis stem cells primarily in the bone marrow of specific bones in the body.

    • Autologous transplantation involves removing bone marrow or peripheral blood stem cells from the patient and administering them after harvesting or replacing the patient’s stem cells with peripheral blood stem cells after the patient receives high-dose chemotherapy or radiation.

    • In-vitro purging may be used to remove cancerous cells from contaminated cancer cells after stem cell collection.

    • Allogeneic transplantation involves a patient receiving bone marrow from a healthy matched donor who is not an identical twin.

    • Finding a suitable matched donor is important to reduce the risk of post-transplant complications and can take time if the patient does not have a matched sibling.

    • Myeloablative conditioning is designed to ablate the patient’s bone marrow, eradicate cancer cells, suppress the immune system, and open spaces in bone marrow for engraftment of donor stem cells.

    • Reduced intensity conditioning (RIC) regimen uses a much-reduced conditioning regimen and is preferred in the elderly since it causes less toxicity, mixed chimerism upon engraftment, and less graft vs. host disease (GVHD).

    • Non-myeloablative HSCT conditioning regimens use low-dose chemotherapy and/or low-dose total body irradiation, with tumor eradication depending on the graft versus tumor (GVT) effect, which occurs due to donor T-cells.

    • Stem cell mobilization involves increasing the number of circulating stem cells to the peripheral blood for harvesting, with various methods of mobilization such as single-agent granulocyte colony-stimulating factor (G-CSF) or plerixafor.

    • Umbilical cord blood (UCB) stem cells are an alternative source of stem cells, with advantages such as ease of collection, no risk for mother or child, and less costly than bone marrow collection, but the small number of stem cells obtained from UCB may require adults to need more than two units.Stem Cell Transplantation: Preparative Regimen, Engraftment, Immunosuppression, and Side Effects

    • Preparative regimen includes Busulfan IV, TBI, VP-16, and medication to prevent GVHD.

    • Stem cell rescue infusion is the intravenous reinfusion of hematopoietic cell graft into the patient following myeloablative or non-myeloablative therapy.

    • Complications of stem cell rescue include facial flushing, tickling sensation in throat, and rare side effects such as bradycardia, abdominal pain, seizure, renal failure, and encephalopathy.

    • Engraftment usually occurs within 2 to 4 weeks following transplantation, and complete recovery of immune function takes much longer, up to several months for autologous transplant recipients and 1 to 2 years for patients receiving allogeneic transplants.

    • Engraftment criteria include sustained ANC >500/mm3 for 3 consecutive days and sustained platelet count 20,000/mm3 for 7 consecutive days.

    • Engraftment failure can be primary or secondary, and the risk factors include aplastic disease, occurrence of GVHD, and use of non-myeloblative therapies.

    • Immunosuppression is used to prevent graft rejection, eradicate host immune system, and suppress donor immune system to minimize recognition of host cells as foreign.

    • Commonly used immunosuppressants include calcineurin inhibitors, mycophenolate mofetil, methotrexate, corticosteroids, and mTOR inhibitor.

    • Recovery after stem cell transplantation can be complicated by mucositis/stomatitis, venoocclusive occlusion, and interstitial pneumonitis.

    • B-cell counts usually return to normal within 3-12 months post-transplant, and recovery may not occur until at least 2 years in patients with chronic GVHD.

    • Short-term side effects of stem cell transplantation include nausea, vomiting, diarrhea, stomatitis, hair loss, loss of appetite, fatigue, and electrolyte wasting.

    • Long-term side effects of stem cell transplantation include secondary malignancies, reproductive and sexual issues, body image changes, skin changes, and memory loss.

    Hematopoietic Stem Cell Transplantation: Types, Donor Sources, and Conditioning Regimens

    • Hematopoietic stem cell transplantation (HSCT) involves infusing hematopoietic progenitor stem cells (HPCs) from a donor to a recipient after a preparative regimen of chemotherapy and/or radiation to re-establish normal hematopoietic and immune function.

    • HSCT is used to treat and cure various malignant and non-malignant disorders.

    • Hematopoietic stem cells (HSCs) are pluripotent stem cells that differentiate into hematopoiesis stem cells primarily in the bone marrow of specific bones in the body.

    • Autologous transplantation involves removing bone marrow or peripheral blood stem cells from the patient and administering them after harvesting or replacing the patient’s stem cells with peripheral blood stem cells after the patient receives high-dose chemotherapy or radiation.

    • In-vitro purging may be used to remove cancerous cells from contaminated cancer cells after stem cell collection.

    • Allogeneic transplantation involves a patient receiving bone marrow from a healthy matched donor who is not an identical twin.

    • Finding a suitable matched donor is important to reduce the risk of post-transplant complications and can take time if the patient does not have a matched sibling.

    • Myeloablative conditioning is designed to ablate the patient’s bone marrow, eradicate cancer cells, suppress the immune system, and open spaces in bone marrow for engraftment of donor stem cells.

    • Reduced intensity conditioning (RIC) regimen uses a much-reduced conditioning regimen and is preferred in the elderly since it causes less toxicity, mixed chimerism upon engraftment, and less graft vs. host disease (GVHD).

    • Non-myeloablative HSCT conditioning regimens use low-dose chemotherapy and/or low-dose total body irradiation, with tumor eradication depending on the graft versus tumor (GVT) effect, which occurs due to donor T-cells.

    • Stem cell mobilization involves increasing the number of circulating stem cells to the peripheral blood for harvesting, with various methods of mobilization such as single-agent granulocyte colony-stimulating factor (G-CSF) or plerixafor.

    • Umbilical cord blood (UCB) stem cells are an alternative source of stem cells, with advantages such as ease of collection, no risk for mother or child, and less costly than bone marrow collection, but the small number of stem cells obtained from UCB may require adults to need more than two units.Stem Cell Transplantation: Preparative Regimen, Engraftment, Immunosuppression, and Side Effects

    • Preparative regimen includes Busulfan IV, TBI, VP-16, and medication to prevent GVHD.

    • Stem cell rescue infusion is the intravenous reinfusion of hematopoietic cell graft into the patient following myeloablative or non-myeloablative therapy.

    • Complications of stem cell rescue include facial flushing, tickling sensation in throat, and rare side effects such as bradycardia, abdominal pain, seizure, renal failure, and encephalopathy.

    • Engraftment usually occurs within 2 to 4 weeks following transplantation, and complete recovery of immune function takes much longer, up to several months for autologous transplant recipients and 1 to 2 years for patients receiving allogeneic transplants.

    • Engraftment criteria include sustained ANC >500/mm3 for 3 consecutive days and sustained platelet count 20,000/mm3 for 7 consecutive days.

    • Engraftment failure can be primary or secondary, and the risk factors include aplastic disease, occurrence of GVHD, and use of non-myeloblative therapies.

    • Immunosuppression is used to prevent graft rejection, eradicate host immune system, and suppress donor immune system to minimize recognition of host cells as foreign.

    • Commonly used immunosuppressants include calcineurin inhibitors, mycophenolate mofetil, methotrexate, corticosteroids, and mTOR inhibitor.

    • Recovery after stem cell transplantation can be complicated by mucositis/stomatitis, venoocclusive occlusion, and interstitial pneumonitis.

    • B-cell counts usually return to normal within 3-12 months post-transplant, and recovery may not occur until at least 2 years in patients with chronic GVHD.

    • Short-term side effects of stem cell transplantation include nausea, vomiting, diarrhea, stomatitis, hair loss, loss of appetite, fatigue, and electrolyte wasting.

    • Long-term side effects of stem cell transplantation include secondary malignancies, reproductive and sexual issues, body image changes, skin changes, and memory loss.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    HSCT_2023.pptx

    Description

    Test your knowledge on Hematopoietic Stem Cell Transplantation with this quiz! From the different types of HSCT to donor sources and conditioning regimens, this quiz covers it all. Learn about the preparative regimen, engraftment, immunosuppression, and potential side effects that come with stem cell transplantation. This quiz will help you understand the medical procedure that is used to treat and cure various malignant and non-malignant disorders.

    More Like This

    Use Quizgecko on...
    Browser
    Open
    Browser
    Browser